UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A randomized trial to evaluate the effects of a supervised exercise program on insomnia in patients with non-metastatic breast cancer undergoing chemotherapy: design of the FATSOMCAN study

BMC cancer, 2023-05, Vol.23 (1), p.449-449, Article 449

2023

Volltextzugriff (PDF)

Feasibility of health-related quality of life (HRQoL) assessment for cancer patients using electronic patient-reported outcome (ePRO) in daily clinical practice

Quality of life research, 2021-11, Vol.30 (11), p.3255-3266

2021

Volltextzugriff (PDF)

ATG9A Is Overexpressed in Triple Negative Breast Cancer and Its In Vitro Extinction Leads to the Inhibition of Pro-Cancer Phenotypes

Cells (Basel, Switzerland), 2018-12, Vol.7 (12), p.248

2018

Volltextzugriff (PDF)

How to manage patients with corticosteroids in oncology in the era of immunotherapy?

European journal of cancer (1990), 2020-12, Vol.141, p.239-251

2020

Volltextzugriff (PDF)

PARP inhibitors (PARPi) prolongation after local therapy for oligo-metastatic progression in relapsed ovarian cancer patients

Gynecologic oncology, 2023-06, Vol.173, p.98-105

2023

Volltextzugriff (PDF)

Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients

European journal of cancer (1990), 2021-06, Vol.150, p.1-9

2021

Volltextzugriff (PDF)

Efficacy of trabectedin in metastatic solitary fibrous tumor

Rare tumors, 2011-07, Vol.3 (3), p.e29-94

2011

Volltextzugriff (PDF)

Rapalog combined with CCR4 antagonist improves anticancer vaccines efficacy

International journal of cancer, 2018-12, Vol.143 (11), p.3008-3018

2018

Volltextzugriff (PDF)

Prognostic and predictive indicators in early-stage breast cancer and the role of genomic profiling: Focus on the Oncotype DX® Breast Recurrence Score Assay

European journal of surgical oncology, 2017-05, Vol.43 (5), p.921-930

2017

Volltextzugriff (PDF)

Discordances in Estrogen Receptor Status, Progesterone Receptor Status, and HER2 Status Between Primary Breast Cancer and Metastasis

The oncologist (Dayton, Ohio), 2013-06, Vol.18 (6), p.667-674

2013

Volltextzugriff (PDF)

Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER)

European journal of cancer (1990), 2021-06, Vol.150, p.232-239

2021

Volltextzugriff (PDF)

Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14), p.4100-4112

2016

Volltextzugriff (PDF)

Cytoreductive Surgery and Intraperitoneal Chemotherapy in Advanced Serous Epithelial Ovarian Cancer: A 14-Year French Retrospective Single-Center Study of 124 Patients

Annals of surgical oncology, 2022-05, Vol.29 (5), p.3322-3334

2022

Volltextzugriff (PDF)

928 Subgroup analysis by chemotherapy regimen in the ENGOT-Ov41/GEICO 69-O/ANITA phase 3 trial evaluating atezolizumab combined with a platinum doublet and maintenance niraparib for late-relapsing ovarian cancer

International journal of gynecological cancer, 2024-03, Vol.34 (Suppl 1), p.A581-A582

2024

Volltextzugriff (PDF)

Prognostic Factors for Long-Term Eribulin Response in a Cohort of Patients With HER2-Negative Metastatic Breast Cancer

Clinical breast cancer, 2024-10, Vol.24 (7), p.e622-e632.e5

2024

Volltextzugriff (PDF)

TEDOVA: vaccine OSE2101 +/- pembrolizumab as maintenance in platinum-sensitive recurrent ovarian cancer

Future oncology (London, England), 2024-08, p.1

2024

Volltextzugriff (PDF)

To what extent do age, stage and treatment influence survival after invasive cervical cancer: a French population-based study

Cancer causes & control, 2022-03, Vol.33 (3), p.403-415

2022

Volltextzugriff (PDF)

Immunomodulatory effects of everolimus in a long responsive patient with metastatic renal cell carcinoma

Journal of immunotherapy (1997), 2014-01, Vol.37 (1), p.51-54

2014

Volltextzugriff (PDF)

In the Era of Genomics, Should Tumor Size Be Reconsidered as a Criterion for Neoadjuvant Chemotherapy?

The oncologist (Dayton, Ohio), 2015-04, Vol.20 (4), p.344-350

2015

Volltextzugriff (PDF)

First description of a double heterozygosity for BRCA1 and BRCA2 pathogenic variants in a French metastatic breast cancer patient: A case report

Oncology reports, 2017-03, Vol.37 (3), p.1573-1578

2017

Volltextzugriff (PDF)

Impact of Chemotherapy Beyond the Third Line in Patients With Recurrent Epithelial Ovarian Cancer

International journal of gynecological cancer, 2016-02, Vol.26 (2), p.261-267

2016

Volltextzugriff (PDF)

Efficacy, safety and cost of eribulin in patients with metastatic breast cancer

Bulletin du cancer, 2015-09, Vol.102 (9), p.737

2015

Volltextzugriff (PDF)

EGFR/HER1: a target life

Bulletin du cancer, 2012-02, Vol.99 (2), p.181

2012

Volltextzugriff (PDF)

Targeting the RAS signalling pathway in cancer

Bulletin du cancer, 2011-10, Vol.98 (9), p.1019

2011

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(36)

Sprache

Englisch
(30)
Französisch
(6)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(32)
Science & Technology
(32)
Humans
(24)
Female
(16)
Cancer
(9)
Middle Aged
(9)
Aged
(8)
Breast Cancer
(8)
Medicine
(7)
Medicine & Public Health
(7)
Patients
(7)
Antineoplastic Agents - Therapeutic Use
(6)
Chemotherapy
(6)
Nuclear Medicine
(6)
Retrospective Studies
(6)
Adult
(5)
Aged, 80 And Over
(5)
Breast Neoplasms - Pathology
(5)
Cardiology
(5)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A randomized trial to evaluate the effects of a supervised exercise program on insomnia in patients with non-metastatic breast cancer undergoing chemotherapy: design of the FATSOMCAN study

Feasibility of health-related quality of life (HRQoL) assessment for cancer patients using electronic patient-reported outcome (ePRO) in daily clinical practice

A Phase II Study Evaluating the Interest to Combine UCPVax, a Telomerase CD4 TH1-Inducer Cancer Vaccine, and Atezolizumab for the Treatment of HPV Positive Cancers: VolATIL Study

ATG9A Is Overexpressed in Triple Negative Breast Cancer and Its In Vitro Extinction Leads to the Inhibition of Pro-Cancer Phenotypes

How to manage patients with corticosteroids in oncology in the era of immunotherapy?

PARP inhibitors (PARPi) prolongation after local therapy for oligo-metastatic progression in relapsed ovarian cancer patients

Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients

Efficacy of trabectedin in metastatic solitary fibrous tumor

Rapalog combined with CCR4 antagonist improves anticancer vaccines efficacy

Prognostic and predictive indicators in early-stage breast cancer and the role of genomic profiling: Focus on the Oncotype DX® Breast Recurrence Score Assay

Discordances in Estrogen Receptor Status, Progesterone Receptor Status, and HER2 Status Between Primary Breast Cancer and Metastasis

Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER)

Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity

Cytoreductive Surgery and Intraperitoneal Chemotherapy in Advanced Serous Epithelial Ovarian Cancer: A 14-Year French Retrospective Single-Center Study of 124 Patients

928 Subgroup analysis by chemotherapy regimen in the ENGOT-Ov41/GEICO 69-O/ANITA phase 3 trial evaluating atezolizumab combined with a platinum doublet and maintenance niraparib for late-relapsing ovarian cancer

Prognostic Factors for Long-Term Eribulin Response in a Cohort of Patients With HER2-Negative Metastatic Breast Cancer

TEDOVA: vaccine OSE2101 +/- pembrolizumab as maintenance in platinum-sensitive recurrent ovarian cancer

To what extent do age, stage and treatment influence survival after invasive cervical cancer: a French population-based study

Immunomodulatory effects of everolimus in a long responsive patient with metastatic renal cell carcinoma

In the Era of Genomics, Should Tumor Size Be Reconsidered as a Criterion for Neoadjuvant Chemotherapy?

First description of a double heterozygosity for BRCA1 and BRCA2 pathogenic variants in a French metastatic breast cancer patient: A case report

Impact of Chemotherapy Beyond the Third Line in Patients With Recurrent Epithelial Ovarian Cancer

Efficacy, safety and cost of eribulin in patients with metastatic breast cancer

EGFR/HER1: a target life

Targeting the RAS signalling pathway in cancer

Aktive Filter

Suchergebnisse filtern